American Tower Corporation AMT
Verdict: Sell. Fair value $168 against a price of $175 on 5 Jan 2026, 4% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: 2024 Net Income grew 52% ($1.48B to $2.25B) while Revenue only grew 1.2% ($10.01B to $10.13B),.... Significant fluctuations in Net Income (2021: $2.57B -> 2023: $1.48B -> 2024: $2.25B) without.... Revenue growth has decelerated significantly: 16% (2021) -> 3% (2022) -> 1.2% (2024)..
Main risks
- Extreme leverage: Equity is only ~5.5% of Total Assets ($3.38B Equity vs $61.08B Assets)
- Significant revenue deceleration: Growth slowed to 1.2% YoY in 2024 from 16% in 2021
- Poor incremental returns: ROIIC of ~5.8% suggests recent capital deployment is generating low returns
- Near-term debt maturity concerns
- 2024 Net Income grew 52% ($1.48B to $2.25B) while Revenue only grew 1.2% ($10.01B to $10.13B),...
- 2024 Net Income grew 52% ($1.48B to $2.25B) while Revenue only grew 1.2% ($10.01B to $10.13B), indicating profit growth is driven by non-operating items or cost-cutting rather than core business expansion.